Lymphocyte-to-monocyte ratio before chemoradiotherapy represents a prognostic predictor for locally advanced rectal cancer

References

• FerlayJSoerjomataramIDikshitRCancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012Int J Cancer20151365E359E38625220842
   PubMed Web of Science ®Google Scholar
• BaileyCEHuCYYouYNIncreasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975–2010JAMA Surg20151501172225372703
   PubMed Web of Science ®Google Scholar
• YangYHuangXSunJPrognostic value of perineural invasion in colorectal cancer: a meta-analysisJ Gastrointest Surg20151961113112225663635
   PubMedGoogle Scholar
• GlimeliusBTiretECervantesAArnoldDESMO Guidelines Working GroupRectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnn Oncol201324Suppl 6vi81vi8824078665
   PubMed Web of Science ®Google Scholar
• FlemingFJPåhlmanLMonsonJRNeoadjuvant therapy in rectal cancerDis Colon Rectum201154790191221654259
   PubMedGoogle Scholar
• GaoYHLinJZAnXNeoadjuvant sandwich treatment with oxaliplatin and capecitabine administered prior to, concurrently with, and following radiation therapy in locally advanced rectal cancer: a prospective phase 2 trialInt J Radiat Oncol Biol Phys20149051153116025442042
   PubMed Web of Science ®Google Scholar
• BhanguAWoodGBrownGDarziATekkisPGoldinRThe role of epithelial mesenchymal transition and resistance to neoadjuvant therapy in locally advanced rectal cancerColorectal Dis2014164O133O14324617665
   PubMed Web of Science ®Google Scholar
• BalkwillFMantovaniAInflammation and cancer: back to Virchow?Lancet2001357925553954511229684
   PubMed Web of Science ®Google Scholar
• MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
   PubMed Web of Science ®Google Scholar
• ChanJCChanDLDiakosCIThe lymphocyte-to-monocyte ratio is a superior predictor of overall survival in comparison to established biomarkers of resectable colorectal cancerAnn Surg2017265353954627070934
   PubMed Web of Science ®Google Scholar
• OzawaTIshiharaSKawaiKImpact of a lymphocyte to monocyte ratio in stage IV colorectal cancerJ Surg Res2015199238639226163330
   PubMed Web of Science ®Google Scholar
• MandardAMDalibardFMandardJCPathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlationsCancer19947311268026868194005
   PubMed Web of Science ®Google Scholar
• CoussensLMWerbZInflammation and cancerNature2002420691786086712490959
   PubMed Web of Science ®Google Scholar
• WuYZhouBPInflammation: a driving force speeds cancer metastasisCell Cycle20098203267327319770594
   PubMed Web of Science ®Google Scholar
• Martínez-LostaoLAnelAPardoJHow do cytotoxic lymphocytes kill cancer cells?Clin Cancer Res201521225047505626567364
   PubMed Web of Science ®Google Scholar
• HoffmannTKDworackiGTsukihiroTSpontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importanceClin Cancer Res2002882553256212171883
   PubMed Web of Science ®Google Scholar
• DunnGPOldLJSchreiberRDThe immunobiology of cancer immunosurveillance and immunoeditingImmunity200421213714815308095
   PubMed Web of Science ®Google Scholar
• RabinowichHCohenRBrudermanISteinerZKlajmanAFunctional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytesCancer Res19874711731773491673
   PubMed Web of Science ®Google Scholar
• MengesTEngelJWeltersIChanges in blood lymphocyte populations after multiple trauma: association with posttraumatic complicationsCrit Care Med199927473374010321662
   PubMed Web of Science ®Google Scholar
• KitayamaJYasudaKKawaiKSunamiENagawaHCirculating lymphocyte number has a positive association with tumor response in neoadjuvant chemoradiotherapy for advanced rectal cancerRadiat Oncol201054720525293
   PubMed Web of Science ®Google Scholar
• NeofytouKSmythECGiakoustidisAThe preoperative lymphocyte-to-monocyte ratio is prognostic of clinical outcomes for patients with liver-only colorectal metastases in the neoadjuvant settingAnn Surg Oncol201522134353436225773876
   PubMedGoogle Scholar
• AugierSCiucciTLuciCCarleGFBlin-WakkachCWakkachAInflammatory blood monocytes contribute to tumor development and represent a privileged target to improve host immunosurveillanceJ Immunol2010185127165717321078911
   PubMedGoogle Scholar
• GaldieroMRBonavitaEBarajonIGarlandaCMantovaniAJaillonSTumor associated macrophages and neutrophils in cancerImmunobiology2013218111402141023891329
   PubMed Web of Science ®Google Scholar
• GoSIKimRBSongHNPrognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancerMed Oncol2014311232325417187
   PubMed Web of Science ®Google Scholar
• EoWKChangHJKwonSHThe lymphocyte-monocyte ratio predicts patient survival and aggressiveness of ovarian cancerJ Cancer20167328929626918042
   PubMed Web of Science ®Google Scholar
• HiraharaNMatsubaraTMizotaYIshibashiSTajimaYPrognostic value of preoperative inflammatory response biomarkers in patients with esophageal cancer who undergo a curative thoracoscopic esophagectomyBMC Surg20161616627650456
   PubMedGoogle Scholar
• HuttererGCStoeckigtCStojakovicTLow preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinomaUrol Oncol20143271041104825027686
   PubMed Web of Science ®Google Scholar
• DorofeevaNAGrigorievaYSNikitinaLSEffects of ERK1/2 kinases inactivation on the nigrostriatal system of Krushinsky-Molodkina rats genetically prone to audiogenic seizuresNeurol Res2017391091892528738742
   PubMed Web of Science ®Google Scholar
• WuQBWangMHuTHeWBWangZQPrognostic role of the lymphocyte-to-monocyte ratio in patients undergoing resection for non-metastatic rectal cancerMedicine (Baltimore)20169544e494527858839
   PubMedGoogle Scholar